Korsana Biosciences, Inc. - 8-K Filing
Korsana Biosciences completed a business combination with former Cyclerion Therapeutics on September 8, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 5.02 of this Current Report on Form 8-K under the heading “Appointment of Directors and Certain Officers” is incorporated herein by reference, 9.01 of this Current Report on Form 8-K is incorporated herein by reference)
Tickers: $CYCN